NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Vistagen Therapeutics, Inc. ("Vistagen" or the "Company") (NASDAQ:VTGN).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are […]
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / (ACCESS NEWSWIRE)-The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Tennant Company ("Tennant" or the "Company") (NYSE:TNC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business
VANCOUVER, BC / ACCESS Newswire / February 27, 2026 / Global Education Communities Corp. ("GECC" or the "Company") (TSX:GEC)(OTCQX International:GECSF) reports the director election voting results from its annual general meeting held today. All of the director nominees, as listed in the management information circular dated January 12, 2026, were elected. Proxy voting as to
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Paysafe Limited ("Paysafe" or the "Company") (NYSE:PSFE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
(NASDAQ:ASND), The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing interval Commercial availability expected during early part of Q2 2026 Rare Pediatric Disease Priority Review Voucher granted in connection with approval Ascendis to host investor conference call Monday, March 2, at 8:00 am ET COPENHAGEN, Denmark,
FDA Approves Once-Weekly YUVIWEL(R) (navepegritide) for Children with Achondroplasia Aged 2 Years and Older GlobeNewswire February 27, 2026 The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing interval Commercial availability expected during early part of Q2 2026 Rare Pediatric Disease Priority Review Voucher granted in connection
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) — With Omega-3 Day approaching on March 3 (03-03), Nordic Naturals conducted a nationwide media tour designed to make consumers pause and reconsider a simple but critical question: Are you getting enough omega-3s? Research shows that more than 80% of Americans fall short of their omega-3 intake, essential
Nordic Naturals and Kate Turner Discuss Why More Than 80% of Americans Are Falling Short on Omega-3s with YourUpdateTV Nationwide media tour conducted with Nordic Naturals in partnership with D S Simon Media on the topic of The Omega-3 Wake-Up Call: Why Diet Alone Isn't Enough Anymore GlobeNewswire February 27, 2026 NEW YORK, Feb. 27,
Vancouver, British Columbia–(Newsfile Corp. – February 27, 2026) – Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF) (“Railtown” or the “Company“) is issuing the following news release to clarify its disclosure pursuant to a recent review of the Company’s continuous disclosure record by the British Columbia Securities Commission (the “BCSC“). October 8, 2025 News Release
Las Vegas, Nevada , Feb. 27, 2026 (GLOBE NEWSWIRE) — In 2026, market instability is no longer episodic. It is embedded. Liquidity can thin without warning. Correlation structures can compress and invert intraday. Execution reliability can deteriorate precisely when risk sensitivity increases. In this landscape, the assumption that capital should remain continuously deployed has become